News

Filter

Current filters:

BiotechnologyLicensing

51 to 60 of 95870 results

Australian biotech bodies propose tax incentive to the senate as a boost to domestic innovation

Australian biotech bodies propose tax incentive to the senate as a boost to domestic innovation

15-08-2014

Australian biotech industry leaders including AusBiotech, Cook Medical Australia and the Export Council…

Anna LavelleAustraliaBiotechnologyCook Medical AustraliaEconomicsRegulationTax reform

Pfizer’s meningococcal B vaccine BLA accepted; gains priority review

Pfizer’s meningococcal B vaccine BLA accepted; gains priority review

15-08-2014

The US Food and Drug Administration has accepted for review the Biologics License Application for bivalent…

Invasive meningococcal diseaseLP2086PfizerPharmaceuticalRegulationrLP2086USAVaccines

Ligand signs Captisol license deal with Avion Pharmaceuticals

Ligand signs Captisol license deal with Avion Pharmaceuticals

15-08-2014

Ligand Pharmaceuticals has signed a commercial license agreement with fellow USA-based Avion Pharmaceuticals,…

Avion PharmaceuticalsBiotechnologyBusiness FinanceCaptisolLicensingLigand PharmaceuticalsUSA

Roche’s Avastin gets FDA approval for use with chemotherapy in cervical cancer

Roche’s Avastin gets FDA approval for use with chemotherapy in cervical cancer

15-08-2014

Swiss drug major Roche has received approval from the US Food and Drug Administration for its drug Avastin…

AvastinCervical cancerOncologyPharmaceuticalRegulationRocheSwitzerland

German stem cell company Vivocell in search for new investors after insolvency

German stem cell company Vivocell in search for new investors after insolvency

15-08-2014

German stem cell technology company Vivocell Biosolutions, based in Langenfeld, has gone into insolvency…

BiotechnologyBusiness FinanceCloningCord bloodDevelopmental biologyFinancialGeneticsGermanyStem cellsVivocell Biosolutions

Oxford BioMedica appoints former Aeterna Zentaris senior vice president Paul Blake as chief development officer

Oxford BioMedica appoints former Aeterna Zentaris senior vice president Paul Blake as chief development officer

15-08-2014

British gene and cell therapy company Oxford BioMedica has appointed Paul Blake as chief development…

BiotechnologyBoardroomOxford BioMedicaPaul BlakeUK

51 to 60 of 95870 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top